| Literature DB >> 32414746 |
Ana Gascón1, Marta Castresana2, Natalia Alzueta3, Marta Marin2, María Pío2, Aitziber Echeverria4.
Abstract
Osteomyelitis is an infection involving bone. Staphylococcus aureus is the pathogen most frequently implicated; less frequently involved are other gram-positive organisms, such as Staphylococcus epidermidis, and also gram-negative organisms. The antibiotic of choice for treatment of osteomyelitis caused by methicillin-resistant staphylococci (MRS) is vancomycin, although other alternatives such as daptomycin or teicoplanin are also considered. Osteomyelitis caused by MRS can be difficult to treat safely and effectively. This case report describes the successful use of daptomycin combined with ceftaroline for the treatment of osteomyelitis caused by methicillin-resistant S. epidermidis (MRSE) in a 54-year-old woman, emphasising the clinical pharmacist's role in antimicrobial stewardship programmes. This alternative combination has been studied in the treatment of methicillin-resistant S. aureus (MRSA), but it may also be useful in MRSE. © European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: hospital pharmacy education; infection control; microbiological control; microbiology; pharmacokinetics and dynamics
Mesh:
Substances:
Year: 2020 PMID: 32414746 PMCID: PMC8403780 DOI: 10.1136/ejhpharm-2019-002183
Source DB: PubMed Journal: Eur J Hosp Pharm ISSN: 2047-9956